Zetiq has developed a unique proprietary platform, the CellDetect. It is registered technology, for the ‎detection of cancer cells via discriminate staining of cancer cells among normal ‎cells, while preserving the morphological features of the cells. The unique platform technology enables color discrimination between red cancer ‎cells and green non-cancer cells. Using a simple in-vitro procedure to stain cells ‎they offer dual-color and morphological diagnostic products that are resource-saving and amendable to automation, in a wide range of cancer indications.‎ Products originating from the platform CellDetect:registered: Technology has achieved ‎positive results in targeted clinical trials, and Zetiq intends to expand ‎the development of products of the CellDetect towards the high market ‎value of cancer diagnosis.

Suzhou Xuguang Kexing Antibody Biotechnology Co., Ltd., established on 2019-09-27, Business scope includes research and development,Sales:biotechnology product;research and development,Production:one type,Class II,Three types of in vitro diagnostic reagents;Biotechnology R&D Services;technology development,technical consulting,Technical Services,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The Eli and Edythe L. Broad Institute of MIT and Harvard (/ˈbroʊd/), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

NEC Corp. engages in the provision of systems, components, services, and integrated solutions for computing and communications applications. It operates through the following segments: Public Business, Enterprise Business, Telecom Carrier Business, System Platform Business, and Others. The Public Business segment provides system integration (system architecture and consulting), support (maintenance), outsourcing and cloud services, and system equipment for public, medical and financial institutions. The Enterprise Business segment offers information technology solutions for manufacturing, retail, and services. The Telecom Carrier Business segment supplies equipment to telecom carriers for network implementation, along with network control platform systems and operating services. The System Platform Business deals with products from business such as from terminals to network and computer equipment, software products, and service platforms. The Others segment includes smart energy solutions, mobile phones, and lighting equipment businesses. The company was founded by Kunihiko Iwadare on July 17, 1899 and is headquartered in Tokyo, Japan.

Hangzhou Qingzhenghong Technology Co., Ltd., established on 2014-05-20, Business scope includes technology research and development,Technical Services,Technology processing and technology transfer:network technology,biologics,chemical agent,biomedical products;wholesale,retail:Laboratory Instruments and Consumables,laboratory reagent(Removal of hazardous chemicals and precursor chemicals).

Kunming Sino Pharmaceutical Co., Ltd., established on 1998-06-24, Business scope includes mixture,oral liquid,tablet,hard capsule,Granules,API(Amlodipine mesylate,rehabilitation new,Erigeron extract),pill(Pellets),tincture;medical instruments(Class II6854-11rinse,ventilation,pressure relief device)production,Sales,Technology Transfer and Consulting;Goods and technology import and export business(Hazardous Chemicals,Except for ammonia-related refrigeration industry and national restricted prohibited products)(It is not allowed to engage in restricted industries in the zone’s industrial policies in the Economic Development Zone.,Prohibited industries)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (doing business as Chia Tai-Tianqing Pharmaceutical Co Ltd) is a company headquartered in Lianyungang, China. The firm manufactures pharmaceutical products. It was founded in 1969. Kang Xin Yu is the current CEO of the firm.

Guangzhou Xingliao Biotechnology Co., Ltd., established on 2015-04-03, Business scope includes natural science research and experimental development;Stem Cell Technology Research,to develop;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;Biotechnology Development Services;Biotechnology Consulting,communication service;Agricultural Machinery Wholesale;Machinery Parts Wholesale;Wholesale of electrical equipment;General Machinery Sales;Sales of electrical machinery and equipment;Wholesale of environmental protection equipment;Wholesale of safety technology and prevention products;Special Equipment Sales;trade agent;Import and export(Excluding franchised products);Technology Import and Export;Commodity wholesale trade(Except for licensed and approved products);Internet Merchandise Sales(Except for licensed and approved products);Fire Equipment,Wholesale of equipment;Wholesale of cosmetics and hygiene products;Retailing of cosmetics and hygiene products;Medical supplies and equipment retail(Does not contain drugs and medical devices);Retailing of office equipment consumables;Communication Equipment Retail;security technology prevention product retail;General machinery and equipment retail;Machinery Parts Retail;Commodity retail trade(Except for licensed and approved products);Internet commodity retail(Except for licensed and approved products);Planning creative services;Business Management Consulting Services;Trade Advisory Services;Digital Animation Production;Advertising;Business Card Printing Service;Corporate Image Planning Service;Marketing Planning Service;Computer inkjet,Printing service;Commodity Information Consulting Service;Other office equipment maintenance;Medical Equipment Repair;

Compugen is a drug and diagnostic discovery company providing novel product candidates addressing important unmet therapeutic and diagnostic needs to pharmaceutical, biotech and diagnostic companies under milestone and royalty bearing, or other revenue sharing agreements. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts consist of in silico (by computer) hypothesis-driven product candidate prediction and selection followed by in vitro and in vivo experimental validation. Compugen's unique in silico prediction and selection capabilities are based on a broad and continuously growing infrastructure of proprietary scientific understandings and predictive platforms, algorithms, machine learning systems and other computational biology tools. Industry collaborations may be entered into before product candidate discovery is undertaken pursuant to "discovery on demand" type arrangements, or with respect to existing product candidates, can be initiated prior to, or at the proof of concept stage, or after selected preclinical activities have been undertaken by Compugen. In 2002, Compugen established an affiliate, Evogene Ltd. (TASE: EVGN.TA) - to utilize certain of the Company's in silico predictive discovery capabilities in agricultural biotechnology.

Wenzhou Kangtai Biotechnology Co., Ltd., established on 2000-01-07, Business scope includes general items:Biochemical product technology research and development;New material technology research and development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Import and export;Technology Import and Export;Manufacturing of experimental analysis instruments;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);R&D of industrial enzyme preparations;Veterinary special instruments and machinery manufacturing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Shenzhen United Bohai Biotechnology Co., Ltd., established on 2015-06-04, Business scope includes general business items:chemicals,natural medicine,Gene medicine,Immune Cells,Research and development of biotechnology products(No restricted items)and technology transfer;Disinfection and sterilization products,hygiene products,Investment in cosmetics,technology R & D;Laboratory Biological Reagents,Sales of consumables,Basic research in biomedical technology;Leasing of medical equipment(Excluding finance lease);Invest in the medical industry,Invest in medical projects(Specific projects will be reported separately);Provide logistics management services for hospitals(Does not contain specific operating medical services);Technology Transfer for Bioengineering Technology Projects,technical consulting,Economic Information Consulting;Domestic Trade,Operating import and export business(Does not contain franchise,Exclusive control,Monopoly);(above laws,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating).,The licensing program is:

National Cancer Center Korea is a South Korean company located in Goyang-si and ultimately controlled by the Government of South Korea. The firm provides clinical and medical research services.

Wenzhou De'an Medical Laboratory Co., Ltd., established on 2009-02-13, The scope of business includes medical laboratory,clinical body fluid,blood specialty,clinical chemistry laboratory,clinical immunization,Serology major(Operate within the validity period of the medical institution's practice license);Medical Technology Development,Technical Services,technical consulting;Business Management Consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Peking Union Medical College Hospital, also known as Beijing Xiehe Hospital (Chinese: 北京协和医院), is a renowned general hospital in Beijing, China. It was founded in 1921 by Rockefeller Foundation and is affiliated to both Peking Union Medical College (PUMC) and Chinese Academy of Medical Sciences (CAMS). During the Cultural Revolution, it was renamed the "Anti-imperialist Hospital".

Nanjing McKellen Biomedical Technology Co., Ltd., established on 2014-07-30, Business scope includes biomedical technology research and development and technical services;Biomedical Technology Consulting and Transfer;Class I medical device sales;Self-operated and agent import and export business of various commodities.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)